Speakers include moderator John James, founder of Innovate Arkansas client firm Acumen Brands; Carl Tannenbaum, chief economist at Northern Trust; John Silvia, the managing director and chief economist for Wells Fargo and Kathy Deck, director of the CBER.
InterveXion Therapeutics LLC, a University of Arkansas for Medical Sciences BioVentures startup company, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.
The firms making the announcement with Gov. Asa Hutchinson from downtown Conway were Metova Inc., of Franklin, Tennessee; Atlanta-based Big Cloud Analytics; and Conway's Eyenalyze.
The Northwest Arkansas Council announced a three-year development plan for the region at its winter meeting Tuesday in Rogers.